Physician

Adil Farooqui, MD

According to 2025 Medicare claims, Adil Farooqui, MD (NPI: 1417016163) practices colorectal surgery (formerly proctology) in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP (NPI: 1043242563; TIN: 951750445) and primary practice location at 90034-1702.

Farooqui's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 20 traditional Medicare patients, billed 37 HCPCS/CPT codes, and received $2,759 in Medicare payments. Part D data shows 334 prescription claims across 105 beneficiaries totaling $4,717 in drug costs, led by Gavilyte-C (Peg3350/Sod Sulf,bicarb,cl/Kcl). Open Payments data shows 1 records totaling $56. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,311 and ending at $4,717. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9K$3.8K2021 Medicare payment: $3,777 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,759 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20211116$3,777
2022N/RN/RN/R
2023N/RN/RN/R
20242037$2,759

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.8K$14K2015 Drug cost: $4,311 (USD; Tot_Drug_Cst)2016 Drug cost: $7,337 (USD; Tot_Drug_Cst)2017 Drug cost: $4,163 (USD; Tot_Drug_Cst)2018 Drug cost: $4,266 (USD; Tot_Drug_Cst)2019 Drug cost: $3,456 (USD; Tot_Drug_Cst)2020 Drug cost: $7,645 (USD; Tot_Drug_Cst)2021 Drug cost: $3,650 (USD; Tot_Drug_Cst)2022 Drug cost: $2,954 (USD; Tot_Drug_Cst)2023 Drug cost: $13,566 (USD; Tot_Drug_Cst)2024 Drug cost: $4,717 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201570164$4,311
201670178$7,337
201791226$4,163
201869186$4,266
201976177$3,456
202075202$7,645
202151141$3,650
202279222$2,954
2023112420$13,566
2024105334$4,717

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl4164$918
Enoxaparin SodiumEnoxaparin Sodium12280$855
GabapentinGabapentin721,530$643
Neomycin SulfateNeomycin Sulfate4252$544
Tramadol HclTramadol Hcl67319$416

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$56Ethicon US, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adil Farooqui, MD?

Tedicare shows public-source Medicare data for Adil Farooqui, MD (NPI 1417016163), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adil Farooqui, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adil Farooqui, MD?

Adil Farooqui, MD is linked to SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP (billing NPI 1043242563) in the available physician profile data.

Does Adil Farooqui, MD have Open Payments data?

Adil Farooqui, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.